94135-1 |
Funeral service licensee identifier |
ID |
Facility |
Pt |
Nom |
|
|
ACTIVE |
Funeral service licensee identifier Facility |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ADMIN.FACILITY |
|
94135-1 |
|
|
|
|
Observation |
|
|
|
0 |
Funeral service licensee ID Facility |
|
|
|
|
|
ADMIN; Ident; Identifier; Nominal; Point in time; Random |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
94136-9 |
Controlled substance agreement |
Find |
{Setting} |
Pt |
Doc |
{Role} |
|
ACTIVE |
Controlled substance agreement |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
94136-9 |
|
{Role} |
|
|
Both |
|
|
|
0 |
Cntrl Substance Agreement |
|
|
|
|
|
Cntrl Substance Agreement; Contract; DOC.ONT; Document; Finding; Findings; Point in time; Random; Subs |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
94137-7 |
HEDIS 2020 Value Sets |
- |
^Patient |
Pt |
- |
|
|
DISCOURAGED |
HEDIS 2020 Value Sets |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.HEDIS |
|
94137-7 |
|
|
|
|
|
|
|
|
0 |
HEDIS 2020 Value Sets |
|
|
|
|
|
Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random |
2.69 |
2.67 |
|
Convenience group |
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
94138-5 |
HEDIS 2020 Value Set - BMI |
- |
^Patient |
Pt |
- |
|
|
DISCOURAGED |
HEDIS 2020 Value Set - BMI |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.HEDIS |
|
94138-5 |
|
|
|
|
|
|
|
|
0 |
HEDIS 2020 BMI |
|
|
|
|
|
HEDIS 2020 BMI; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random |
2.69 |
2.67 |
|
Convenience group |
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
94139-3 |
HEDIS 2020 Value Set - BMI percentile |
- |
^Patient |
Pt |
- |
|
|
DISCOURAGED |
HEDIS 2020 Value Set - BMI percentile |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.HEDIS |
|
94139-3 |
|
|
|
|
|
|
|
|
0 |
HEDIS 2020 BMI prctl |
|
|
|
|
|
HEDIS 2020 BMI; HEDIS 2020 BMI prctl; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random |
2.69 |
2.67 |
|
Convenience group |
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
9414-4 |
Phosphoserine |
SCnc |
Urine |
24H |
Qn |
|
|
ACTIVE |
Phosphoserine [Moles/volume] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
9414-4 |
|
|
|
|
Observation |
|
|
|
0 |
Phosphoserine 24h Ur-sCnc |
|
|
|
Y |
|
1 day; 24 hours; 24HR; Chemistry; Level; PS; QNT; Quan; Quant; Quantitative; Substance Concentration; UA; UR; Urn |
2.73 |
1.0i |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
94140-1 |
HEDIS 2020 Value Set - CT Colonography |
- |
^Patient |
Pt |
- |
|
|
DISCOURAGED |
HEDIS 2020 Value Set - CT Colonography |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.HEDIS |
|
94140-1 |
|
|
|
|
|
|
|
|
0 |
HEDIS 2020 CT Colongrphy |
|
|
|
|
|
HEDIS 2020 CT Colongrphy; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random |
2.69 |
2.67 |
|
Convenience group |
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
94141-9 |
HEDIS 2020 Value Set - Mammography |
- |
^Patient |
Pt |
- |
|
|
DISCOURAGED |
HEDIS 2020 Value Set - Mammography |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.HEDIS |
|
94141-9 |
|
|
|
|
|
|
|
|
0 |
HEDIS 2020 Mammography |
|
|
|
|
|
HEDIS 2020 Mammography; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random |
2.69 |
2.67 |
|
Convenience group |
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
94142-7 |
HEDIS 2020 Value Set - Urine Protein Tests |
- |
^Patient |
Pt |
- |
|
|
DISCOURAGED |
HEDIS 2020 Value Set - Urine Protein Tests |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.HEDIS |
|
94142-7 |
|
|
|
|
|
|
|
|
0 |
HEDIS 2020 Urine Prot Tests |
|
|
|
|
|
HEDIS 2020 Urine Prot Tests; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; PR; Prot; Random |
2.69 |
2.67 |
|
Convenience group |
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
94143-5 |
HEDIS 2020 Value Set - Diastolic Blood Pressure |
- |
^Patient |
Pt |
- |
|
|
DISCOURAGED |
HEDIS 2020 Value Set - Diastolic Blood Pressure |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.HEDIS |
|
94143-5 |
|
|
|
|
|
|
|
|
0 |
HEDIS 2020 Diastolic BP |
|
|
|
|
|
BP; Dias; Diast; Diastoli; HEDIS 2020 Diastolic BP; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random |
2.69 |
2.67 |
|
Convenience group |
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
94144-3 |
HEDIS 2020 Value Set - Systolic Blood Pressure |
- |
^Patient |
Pt |
- |
|
|
DISCOURAGED |
HEDIS 2020 Value Set - Systolic Blood Pressure |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.HEDIS |
|
94144-3 |
|
|
|
|
|
|
|
|
0 |
HEDIS 2020 Systolic BP |
|
|
|
|
|
BP; HEDIS 2020 Systolic BP; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random |
2.69 |
2.67 |
|
Convenience group |
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
94145-0 |
Crotonylglycine/Creatinine |
SRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Crotonylglycine/Creatinine [Molar ratio] in Urine |
|
ADD |
DefinitionDescription |
|
|
mmol/mol creatinine |
|
|
|
|
|
|
CHEM |
|
94145-0 |
|
|
|
|
Observation |
|
|
|
0 |
Crotonylglycine/Creat Ur-sRto |
|
|
|
|
|
Chemistry; CR; Crea; Creat; Esoteric; N-crotonylglycine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn |
2.68 |
2.68 |
|
|
|
|
|
|
|
mmol/mol{creat} |
|
|
|
0 |
94146-8 |
2-Decenedioate/Creatinine |
SRto |
Urine |
Pt |
Qn |
|
|
ACTIVE |
2-Decenedioate/Creatinine [Molar ratio] in Urine |
|
ADD |
DefinitionDescription |
|
|
mmol/mol creatinine |
|
|
|
|
|
|
CHEM |
|
94146-8 |
|
|
|
|
Observation |
|
|
|
0 |
2-Decenedioate/Creat Ur-sRto |
|
|
|
|
|
2E-decenedioate; 2E-decenedioic acid; Chemistry; CR; Crea; Creat; Decenedioic acid; Esoteric; II; Medium chain acyl-CoA dehydrogenase deficiency; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn |
2.68 |
2.68 |
|
|
|
|
|
|
|
mmol/mol{creat} |
|
|
|
0 |
94147-6 |
B-bump |
Find |
Mitral valve |
Pt |
Ord |
US.M-mode |
|
ACTIVE |
Mitral valve B-bump by US.M-mode |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CARD.US |
|
94147-6 |
|
US.M-mode |
|
|
Observation |
|
|
|
0 |
MV B-bump M-mode |
|
|
|
|
|
A-C shoulder; B bump; B notch; B-B' step; Beta inflection; CARD.US; Cardio; Cardiology; Echography; Finding; Findings; Heart Disease; Interruption of AC slope; MM; mmode; MV; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sonogram; Sonograph; Sonography; ULS; Ultrasound |
2.68 |
2.68 |
|
|
|
|
|
|
|
|
|
|
|
0 |
94148-4 |
Blood flow reversal.holodiastolic |
Find |
Aorta.thoracic.descending |
Pt |
Ord |
US.doppler |
|
ACTIVE |
Descending thoracic aorta Holodiastolic flow reversal by US.doppler |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CARD.US |
|
94148-4 |
|
US.doppler |
|
|
Observation |
|
|
|
0 |
DTA Holodias flow reversal DOP |
|
|
|
|
|
AO; Aortic; Bld flow; CARD.US; Cardio; Cardiology; DOP; DTA; DUPLEX; Dynamic; Echography; Finding; Findings; Heart Disease; Holodias flow reversal; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sonogram; Sonograph; Sonography; Thorax; ULS; Ultrasound |
2.68 |
2.68 |
|
|
|
|
|
|
|
|
|
|
|
0 |
94149-2 |
Heterophile Ab |
PrThr |
Ser/Plas/Bld |
Pt |
Ord |
IA.rapid |
|
ACTIVE |
Heterophile Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
94149-2 |
|
IA.rapid |
|
|
Both |
|
|
|
0 |
Heteroph Ab SerPlBld Ql IA.rapid |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blood; EIA; ELFA; ELISA; Enzyme immunoassay; Epstein-Barr virus; Hetero; Heteroph; Hetr; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Mono screen; Mono slide; Mono spot; Mono test; Mononucleosis screen; Mononucleosis test; Monospot; Ordinal; Pl; PlasBld; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; SUDS; WB; Whole blood |
2.68 |
2.68 |
|
|
|
|
|
|
|
|
|
|
|
0 |
9415-1 |
carBAMazepine 10,11-Epoxide |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Carbamazepine 10,11-Epoxide [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
9415-1 |
|
|
|
|
Both |
|
|
|
0 |
Carbamazepine EP SerPl-mCnc |
|
|
|
Y |
|
Carbamazapine; Carbamazepine EP; Carbamazepine metabolite; Carbamezapine; Carbazepine; CRBM; DRUG/TOXICOLOGY; Drugs; Epitol; Level; Mass concentration; Neuro; Neurology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tegretol; Teril |
2.73 |
1.0i |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
94151-8 |
Bacteria.carbapenem resistant |
Prid |
XXX |
Pt |
Nom |
Organism specific culture |
|
ACTIVE |
Bacteria.carbapenem resistant identified in Specimen by Organism specific culture |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
94151-8 |
|
Organism specific culture |
|
|
Both |
|
|
|
0 |
Bacteria.carbpm resist Spec Cult |
|
|
|
|
|
Bact; Bacteria.carbpm resist; C&S; Carbapenemase; carbapenem-resistant Enterobacteriaceae; carbapenem-resistant Klebsiella pneumoniae; CRE; CRKP; Cult; Cultures; Enterobacteriaceae; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; Unspecified |
2.79 |
2.68 |
|
|
|
|
|
|
|
|
|
|
Release 2.79: COMPONENT: Triggered by the coll w SCT:The understanding is that the word "identified" refers to the property "PRID", its presence in the component is redundant to the property. Therefore it is better to remove "identified" from the component.; |
0 |
94157-5 |
PhenX - age of initiation of first cigarette use - adult protocol 030703 |
- |
^Patient |
Pt |
- |
PhenX |
|
ACTIVE |
PhenX - age of initiation of first cigarette use - adult protocol 030703 |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.PHENX |
|
94157-5 |
|
PhenX |
|
|
Both |
|
|
|
0 |
Age init cig use adult proto |
|
|
|
|
|
Age init cig use adult proto; Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random; Smoke; Smokes; Smoking; Tobacco |
2.68 |
2.68 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
94158-3 |
PhenX - ethnicity protocol 010502 |
- |
^Patient |
Pt |
- |
PhenX |
|
ACTIVE |
PhenX - ethnicity protocol 010502 |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.PHENX |
|
94158-3 |
|
PhenX |
|
|
Both |
|
|
|
0 |
PhenX - ethnicity protocol |
|
|
|
|
|
Pan; Panel; PANEL.PHENX; Panl; Pnl; Point in time; Random |
2.68 |
2.68 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
9416-9 |
Acyclovir |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Acyclovir [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
DRUG/TOX |
|
9416-9 |
|
|
|
|
Both |
|
|
|
0 |
Acyclovir SerPl-mCnc |
|
|
|
Y |
|
Aciclovir; Acifur; ACV; Acycloguanosine; Avirax; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Zovirax |
2.73 |
1.0i |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
94161-7 |
PROMIS parent proxy item bank - mobility - version 1.0 |
- |
^Patient |
7D |
- |
PROMIS.PARENTPROXY |
|
ACTIVE |
PROMIS parent proxy item bank - mobility - version 1.0 |
|
ADD |
DefinitionDescription |
|
|
|
|
Copyright �© 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx |
|
|
|
|
PANEL.SURVEY.PROMIS |
|
94161-7 |
|
PROMIS.PARENTPROXY |
|
|
Order |
|
|
|
0 |
|
|
|
|
|
|
Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; promise; Survey; SURVEY.PROMIS |
2.68 |
2.68 |
|
Panel |
|
|
Copyright �© 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx |
|
|
|
|
|
|
0 |
94162-5 |
PROMIS parent proxy item bank - pain interference - version 1.0 |
- |
^Patient |
7D |
- |
PROMIS.PARENTPROXY |
|
ACTIVE |
PROMIS parent proxy item bank - pain interference - version 1.0 |
|
ADD |
DefinitionDescription |
|
|
|
|
Copyright �© 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx |
|
|
|
|
PANEL.SURVEY.PROMIS |
|
94162-5 |
|
PROMIS.PARENTPROXY |
|
|
Order |
|
|
|
0 |
|
|
|
|
|
|
Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; promise; Survey; SURVEY.PROMIS |
2.68 |
2.68 |
|
Panel |
|
|
Copyright �© 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx |
|
|
|
|
|
|
0 |
94163-3 |
PROMIS parent proxy pain interference - version 1.0 T-score |
Tscore |
^Patient |
Pt |
Qn |
PROMIS.PARENTPROXY |
|
ACTIVE |
PROMIS parent proxy pain interference - version 1.0 T-score |
|
ADD |
DefinitionDescription |
|
|
Tscore |
|
Copyright �© 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx |
|
|
|
|
SURVEY.PROMIS |
|
94163-3 |
|
PROMIS.PARENTPROXY |
|
|
Observation |
|
|
|
0 |
|
|
|
|
|
|
Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.PROMIS; T prime; T-score |
2.68 |
2.68 |
|
|
|
|
Copyright �© 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx |
|
|
{Tscore} |
|
|
|
0 |
94164-1 |
PROMIS parent proxy - global health 7 - version 1.0 raw score |
Score |
^Patient |
Pt |
Qn |
PROMIS.PARENTPROXY |
|
ACTIVE |
PROMIS parent proxy - global health 7 - version 1.0 raw score |
|
ADD |
DefinitionDescription |
|
|
score |
|
Copyright �© 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx |
|
|
|
|
SURVEY.PROMIS |
|
94164-1 |
|
PROMIS.PARENTPROXY |
|
|
Observation |
|
|
|
0 |
|
|
|
|
|
|
Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.PROMIS |
2.68 |
2.68 |
|
|
|
|
Copyright �© 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx |
|
|
{score} |
|
|
|
0 |